Login
$SNTI
$0.18 -$0.01 (7.06%) Close

$SNTI 3 SEC Filings

Filed On Filing
21 Jul 2025 Form 3: Baum Bryan Daniel, Director

No securities owned

13 Mar 2025 Form 3: Celadon Partners Spv 24, 10% owner
12 Mar 2025 Form 3: New Enterprise Associates 15, L.p., 10% owner and 6 others

Holds 442,615 shares of Common Stock

11 Mar 2025 Form 3: Hsiung Feng, Director

No securities owned

11 Mar 2025 Form 3: Cross John Harry Iii, Chief Financial Officer

No securities owned

10 Dec 2024 Form 3: Tang Donald F, Director

Holds 10,368 shares of Common Stock

10 Dec 2024 Form 3: Schulz Fran, Director

No securities owned

09 May 2024 Form 3: Li Yvonne, Interim CFO

No securities owned

13 Feb 2023 Form 3: Bayer Healthcare Llc, 10% owner and 3 others

Holds 5,878,488 shares of Common Stock

15 Jul 2022 Form 3: Rajangam Kanya, Chief Medical & Devt. Officer

No securities owned

15 Jun 2022 Form 3: Mathers Edward T, Director

No securities owned

15 Jun 2022 Form 3: New Enterprise Associates 15, L.p., 10% owner and 7 others

Holds 4,426,151 shares of Common Stock

15 Jun 2022 Form 3: Lee Philip J, Chief Technology Officer

Holds 936,424 shares of Common Stock

15 Jun 2022 Form 3: Berland Susan D, Director
15 Jun 2022 Form 3: Collins James J., Director

Holds 176,130 shares of Common Stock

15 Jun 2022 Form 3: Cooperstone Brenda, Director
15 Jun 2022 Form 3: Knobelman Deborah, Chief Financial Officer
15 Jun 2022 Form 3: Herberts Curt A. Iii, Chief Operating Officer

Holds 454,208 shares of Common Stock

15 Jun 2022 Form 3: Lu Timothy K, Director

Holds 559,496 shares of Common Stock

25 May 2021 Form 3: Nishar Dipchand, Director

Holds 10,733 shares of Class A common stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support